HIV/HCV Co-infection

Clinical trial pipeline · Data from ClinicalTrials.gov

See which HIV/HCV Co-infection trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07429864

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

HDV is an RNA virus that infects only in the presence of HBV, affecting about 13% of HBsAg carriers. In Italy, prevalence ranges from 3.2% to 9.3%. It increases…

Italy20 participantsStarted 2025-09-24

All recent trials (100 shown)

CompletedPhase 2

NCT06144086

A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)

This is a phase 2 trial of foscenvivint in liver cirrhosis patients caused by HIV/HCV co-infection with hemophilia to evaluate the efficacy, safety and pharmaco…

Japan5 participantsStarted 2024-05-08

Treatment: Foscenvivint

CompletedPhase 2

NCT00901524

ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patient…

The purpose of this study is to assess the effectiveness of an optimized anti HCV treatment (360μg per week of PegIFN-alpha2a + 18mg/kg/j of Ribavirin for 6 mon…

France58 participantsStarted 2009-06

Treatment: Peg-interféron alpha 2a + ribavirin

HIV/HCV Co-infection

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

All recent trials (100 shown)

A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)

ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patient…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

All recent trials (100 shown)

A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)

ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patient…

HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin

Supporting Treatment Outcomes Among PWID

Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r

Zepatier in Patients with Substance Use

Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV with Hemophilia.

Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection

Maraviroc Efficacy for Hepatitis C

EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV

Evaluation of HCV Care and Treatment for HIV-HCV Co-infected Patients in Decentralised Areas in Vietnam

Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV

Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With…

HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection

Comparing Brief Alcohol Interventions For HIV-HCV Co-infected Persons

Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P

deLIVER: Direct Acting Antiviral Effects on the Liver

Hepatitis C Treatment Study in Myanmar

Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection.

Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa